Nikolaus de Gregorio

University Hospital Ulm, Universität Ulm

Papers

2

Total Citations

81

H-Index

2

About

Dr. Nikolaus de Gregorio is a leading gynecologic oncologist whose research has fundamentally shaped the understanding and management of borderline ovarian tumors (BOT). His primary focus lies in elucidating the clinical behavior and optimizing treatment strategies for these rare ovarian neoplasms. Dr. de Gregorio’s most significant contribution is his leadership in the multicenter AGO ROBOT study, a landmark pattern-of-care investigation that provided critical, evidence-based insights into BOT outcomes. His seminal 2014 paper, which analyzed age-dependent differences in BOT characteristics and prognosis, has been cited over 75 times, establishing a key framework for personalized patient management. This work demonstrated that younger patients exhibit distinct clinical profiles and better outcomes, directly influencing risk stratification and surgical decision-making. By spearheading this comprehensive study with central pathology review, Dr. de Gregorio moved the field beyond small retrospective series, offering robust data that now underpins modern treatment guidelines. His research continues to shape how clinicians approach these challenging tumors, ensuring that care is tailored to individual patient risk.

Research Focus

Key Achievements

2
H-Index
2
Papers
81
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study
75 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 37
🏛 Institutions: University Hospital Ulm, Universität Ulm

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago